Adial Pharmaceuticals, Inc. Stock Analysis & AI Score
Adial Pharmaceuticals, Inc. (ADIL) has an ST Score of 46.2 (C+), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy with a $8.50 price target (+91.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Adial Pharmaceuticals, Inc. (ADIL) has an ST Score of 46.2 (C+), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy with a $8.50 price target (+91.4% upside).
- Strongest
- GrowthA+
- Weakest
- ProfitabilityF
All factor grades
- GrowthA+
- ForecastA-
- Financial StrengthB
- MomentumC+
- ValuationD
- ProfitabilityF
- Piotroski2/9
Contact
ADIL stock: frequently asked questions
What is ADIL's ST Score?
Adial Pharmaceuticals, Inc. (ADIL) has an ST Score of 46.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ADIL a buy, hold, or sell?
Analysts rate ADIL a Buy, with a price target of $8.50 (+91.4% vs the current price). Our ST Score grades it C+ (46.2/100). The ST Score is a data-driven signal, not a recommendation.
What are ADIL's factor grades?
Valuation D, Profitability F, Financial Strength B, Momentum C+, Growth A+, Forecast A-.
What is ADIL's valuation grade?
Adial Pharmaceuticals, Inc. (ADIL) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ADIL's growth grade?
Adial Pharmaceuticals, Inc. (ADIL) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ADIL's profitability grade?
Adial Pharmaceuticals, Inc. (ADIL) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ADIL's financial strength grade?
Adial Pharmaceuticals, Inc. (ADIL) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ADIL?
The average analyst price target for Adial Pharmaceuticals, Inc. (ADIL) is $8.50 from 3 analysts, which is +91.4% versus the recent price of $4.44.
What is ADIL's Piotroski score?
Adial Pharmaceuticals, Inc. (ADIL) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.